Ask AI

Expert Approaches for Drug-Resistant Acinetobacter Infections: The ABCs of HAP and VAP

Treating multidrug-resistant and extensively drug–resistant Acinetobacter baumannii-calcoaceticus (ABC) is a major challenge because of diverse resistance mechanisms in complex patients. Use this program to bridge this clinical gap and learn more about early identification of drug-resistant infections with rapid diagnostic tests and gain strategies for incorporating recent advances in the ABC armamentarium into clinical practice.

Share

Program Content

Activities

Strategies for Carbapenem-Resistant Acinetobacter
Implementing Guidance Into Practice: Strategies for Carbapenem-Resistant Acinetobacter
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Innoviva Specialty Therapeutics, Inc.

Innoviva Specialty Therapeutics, Inc